AffiliationDepartment of Acute Medicine and Critical Care, The Christie, NHS Foundation Trust, Manchester, United Kingdom.
MetadataShow full item record
AbstractBackground: Immune checkpoint inhibitors (ICIs) have a wide range of toxicities affecting potentially any organ system stemming from increased activity within the T-cell lineage similar to that observed in autoimmunity. Case report: A 57-year-old man with metastatic papillary renal cell carcinoma treatment with combination ICI therapy presented with a history of rapidly progressive diplopia. Neurological examination revealed bilateral fatigable ptosis and asymmetrical ophthalmoplegia. His clinical findings were in keeping with an immune-mediated myasthenia gravis. He was immediately commenced on 1 mg/kg of intravenous methylprednisolone and pyridostigmine 60 mg 3 times a day. On day 2 of admission he was given 1 g/kg of intravenous immunoglobulins. He made a rapid and full clinical recovery. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Immune-mediated myasthenia gravis is an important toxicity of ICIs. Early recognition and treatment of this presentation may reduce the significant morbidity and mortality associated with it. Keywords: immune checkpoint inhibitors; myasthenia gravis; toxicity.
CitationHo AK, Cooksley T. Immune Checkpoint Inhibitor-Mediated Myasthenia Gravis. J Emerg Med. 2020.
JournalJournal of Emergency Medicine
- The Terrible Triad of Checkpoint Inhibition: A Case Report of Myasthenia Gravis, Myocarditis, and Myositis Induced by Cemiplimab in a Patient with Metastatic Cutaneous Squamous Cell Carcinoma.
- Authors: Jeyakumar N, Etchegaray M, Henry J, Lelenwa L, Zhao B, Segura A, Buja LM
- Issue date: 2020
- An unusual presentation of myasthenia gravis.
- Authors: Chijoke A, Ogunmodele JA
- Issue date: 2009 Nov-Dec
- Miller Fisher syndrome mimicking ocular myasthenia gravis.
- Authors: Anthony SA, Thurtell MJ, Leigh RJ
- Issue date: 2012 Dec
- Myasthenia gravis and concurrent myositis following PD-L1 checkpoint inhibitor for non-small cell lung cancer.
- Authors: Phua CS, Murad A, Fraser C, Bray V, Cappelen-Smith C
- Issue date: 2020
- Delayed Diagnosis of Atypical Presentation of Myasthenia Gravis.
- Authors: Mustafa MS, Marshal M, Ahern E, Crowley P
- Issue date: 2018